Svein Solheim

ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 8

Top Venues

Journal of immunology research

Mediators of inflammation

Journal of lipids

Journal of diabetes research

Oslo universitetssykehus Ullevål

University of Oslo (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Oslo universitetssykehus Ullevål Oct 20 2008

Norway

Senior consultant :: Department of Cardiology

Education History

University of Oslo Jan 01 2004 - Jun 01 2007

Norway

PHD :: Faculty of Medicine

Publications

Trine Baur Opstad, Jostein Nordeng, Alf-Aage R Pettersen, Sissel Åkra, Vibeke Bratseth, Hani Zaidi, Ragnhild Helseth, Svein Solheim, Ingebjørg Seljeflot
The NLRP3 Genetic Variant (rs10754555) Reduces the Risk of Adverse Outcome in Middle-Aged Patients with Chronic Coronary Syndrome. Journal of immunology research 2022 (2022)
Trine Baur Opstad, Jostein Nordeng, Alf-Aage R Pettersen, Sissel Åkra, Vibeke Bratseth, Hani Zaidi, Ragnhild Helseth, Svein Solheim, Ingebjørg Seljeflot
The NLRP3 Genetic Variant (rs10754555) Reduces the Risk of Adverse Outcome in Middle-Aged Patients with Chronic Coronary Syndrome. Journal of immunology research 2022 (2022)
Trine Baur Opstad, Jostein Nordeng, Alf-Aage R Pettersen, Sissel Åkra, Vibeke Bratseth, Hani Zaidi, Ragnhild Helseth, Svein Solheim, Ingebjørg Seljeflot
The NLRP3 Genetic Variant (rs10754555) Reduces the Risk of Adverse Outcome in Middle-Aged Patients with Chronic Coronary Syndrome. Journal of immunology research 2022 (2022)
Jostein Nordeng, Hossein Schandiz, Svein Solheim, Sissel Åkra, Pavel Hoffmann, Borghild Roald, Bjørn Bendz, Harald Arnesen, Ragnhild Helseth, Ingebjørg Seljeflot
The Inflammasome Signaling Pathway Is Actively Regulated and Related to Myocardial Damage in Coronary Thrombi from Patients with STEMI. Mediators of inflammation 2021 (2021)
Vibeke Bratseth, Hanna D Margeirsdottir, Gemma Chiva-Blanch, Martin Heier, Svein Solheim, Harald Arnesen, Knut Dahl-Jørgensen, Ingebjørg Seljeflot
Annexin V+ Microvesicles in Children and Adolescents with Type 1 Diabetes: A Prospective Cohort Study. Journal of diabetes research 2020 (2020)
Ida Unhammer Njerve, Sissel Åkra, Thomas W Weiss, Svein Solheim, Reidun Øvstebø, Hans Christian D Aass, Rune Byrkjeland, Harald Arnesen, Ingebjørg Seljeflot
A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery Disease. Mediators of inflammation 2017 (2017)
Ragnhild Helseth, Svein Solheim, Harald Arnesen, Ingebjørg Seljeflot, Trine Baur Opstad
The Time Course of Markers of Neutrophil Extracellular Traps in Patients Undergoing Revascularisation for Acute Myocardial Infarction or Stable Angina Pectoris. Mediators of inflammation 2016 (2016)
Kristian Laake, Ingebjørg Seljeflot, Erik B Schmidt, Peder Myhre, Arnljot Tveit, Harald Arnesen, Svein Solheim
Serum Fatty Acids, Traditional Risk Factors, and Comorbidity as Related to Myocardial Injury in an Elderly Population with Acute Myocardial Infarction. Journal of lipids 2016 (2016)

Svein Solheim.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Svein Solheim